Hospira wins French biosimilar drug tender at 45 pct discount
July 03, 2015 at 11:33 AM EDT
PARIS, July 3 (Reuters) - A major French hospital group has chosen a cheap copycat version of a top-selling drug for treating its patients with rheumatoid arthritis and Crohn's disease in a victory for a new type of medicine known as biosimilars.
